What Are The Chances Of Getting Shingles After Vaccine?

You got the shingles vaccine to avoid shingles. So what happens if you still get a rash a year later? The short answer: it can happen, but it is uncommon. In large clinical trials, the recombinant shingles vaccine (Shingrix) reduced shingles risk by roughly 90% in adults aged 50 and older. That means most vaccinated people never get shingles — but it does not mean zero.

No vaccine works perfectly for every person. The recombinant vaccine is one of the more effective vaccines in adult medicine, yet a small share of vaccinated people still develop shingles. Your personal chance depends on your age, your immune system, and whether you completed both doses.

What Are The Chances Of Getting Shingles After Vaccine?

The chance is low but not zero. In the main clinical trials of the recombinant vaccine, about 90% fewer vaccinated adults developed shingles compared with unvaccinated adults in the same age group. Put another way, protection is high but partial.

That roughly 90% figure comes from trials in adults 50 and older. Protection was somewhat lower in adults 70 and older, though still strong. People with weakened immune systems generally get less protection than healthy adults, which is why the vaccine is often recommended for them anyway — some protection is better than none.

It helps to understand what the vaccine actually does. Shingles is caused by the varicella-zoster virus, the same virus that causes chickenpox. After chickenpox, the virus hides in nerve cells and can reactivate years later. The vaccine does not remove the virus from your body. It trains your immune system to keep the virus suppressed. When that suppression weakens — with age, stress, illness, or immune-suppressing medication — the virus can still break through.

So a vaccinated person who gets shingles is not a vaccine failure in the usual sense. The immune system held the virus back for a long time, and then it didn’t. The vaccine lowers the odds; it does not eliminate them.

How Effective Is The Shingles Vaccine, Really?

Effectiveness depends on which vaccine you mean. There are two shingles vaccines in use, and they are not equal.

The older live vaccine (Zostavax) reduced shingles risk by about 51% in adults 60 and older in its main trial. The newer recombinant vaccine (Shingrix) is substantially more effective, at roughly 90% in adults 50 and older. Because of this gap, the live vaccine has largely been phased out in the United States.

Effectiveness also changes over time. Protection from the recombinant vaccine appears to stay high for several years after vaccination, though it does decline gradually. The live vaccine’s protection dropped more noticeably with age and time since vaccination.

Two doses of the recombinant vaccine are needed for full protection. One dose gives some benefit, but the second dose is what drives protection up to the trial-level figures. If you only got one dose, your protection is lower than the numbers above suggest.

Here is a comparison of the two vaccines based on their main clinical trials:

These are population averages from trials, not promises about any one person. Your own protection could be higher or lower depending on your health and immune status.

Who Is More Likely To Get Shingles After Vaccination?

Some groups face a higher chance than others, even after vaccination. The common thread is a weaker or less reliable immune response.

• Older adults. Immune function declines with age, so protection tends to be somewhat lower in people in their 70s and 80s than in people in their 50s.
• People with weakened immune systems. Conditions like certain cancers, HIV, or autoimmune diseases — and medications like steroids or drugs given after organ transplant — can reduce how well the vaccine works.
• People who did not complete both doses. Skipping the second dose leaves protection meaningfully lower.
• People vaccinated long ago. Protection slowly wanes over years, though the decline is gradual.

One point worth clarifying: getting the vaccine does not cause shingles. The recombinant vaccine contains no live virus, so it cannot reactivate the virus and trigger an outbreak. The live vaccine contains a weakened virus and, in rare cases, has been linked to a shingles-like rash, but this is uncommon.

Does The Vaccine Still Help If You Get Shingles Anyway?

Yes, and this is where the vaccine’s value goes beyond simply preventing the rash. Even when vaccinated people develop shingles, the illness tends to be less severe and complications are less likely.

The most feared complication is postherpetic neuralgia — lingering nerve pain that can last for months after the rash clears. The recombinant vaccine reduced this complication in its trials, and the reduction was substantial. Preventing the rash is the main goal, but reducing the chance of long-term pain matters just as much for many people.

If you are vaccinated and notice a painful, blistering rash on one side of your body, do not assume it cannot be shingles. Contact a clinician promptly. Antiviral treatment works best when started early, ideally within the first few days of the rash appearing. This is true whether or not you have been vaccinated.

Do You Need A Booster Or Another Dose Later?

Current guidance does not call for routine booster doses of the recombinant vaccine after the two-dose series. Protection appears to hold for years, and health authorities have not recommended a third dose for the general population.

That could change as longer-term data come in. Researchers continue to track how protection holds up over a decade and beyond. If you have a weakened immune system, some clinicians may discuss additional doses, but this is a decision to make with your own doctor rather than a general recommendation.

If you received the older live vaccine in the past, current guidance generally recommends getting the recombinant vaccine as well, since the live vaccine’s protection is lower and fades. Talk to a clinician about timing.

What Should You Do If You Think You Have Shingles?

Act quickly. The single most useful thing you can do is see a clinician within the first few days of symptoms. Antiviral medicines work best early, and starting treatment late reduces their benefit.

Watch for a rash that is often painful, tingling, or burning, usually on one side of the body or face. Some people feel pain or odd sensations before any rash appears. Others develop flu-like symptoms first.

Do not wait to see whether the rash spreads or improves on its own. Early treatment is the priority, and a prompt diagnosis helps rule out other conditions that can look similar. A clinician is the right person to sort that out — many skin conditions can mimic shingles, and only an exam can tell them apart.

The bottom line: the shingles vaccine sharply lowers your chance of getting shingles, but it does not make that chance zero. If you are vaccinated and develop symptoms, take them seriously and get seen early.